Effect of cocaine on human immunodeficiency virus-mediated pulmonary endothelial and smooth muscle dysfunction.
Human immunodeficiency virus (HIV)-associated pulmonary arterial hypertension (PAH) is a devastating, noninfectious complication of acquired immune deficiency syndrome, and the majority of HIV-PAH cases occur in individuals with a history of intravenous drug use (IVDU). However, although HIV-1 and IVDU have been associated with PAH independently or in combination, the pathogenesis of the disproportionate presence of HIV-PAH in association with IVDU has yet to be characterized. The objective of this study was to obtain a better understanding of the interactions between HIV-1 and cocaine to help uncover the mechanism(s) of the development of HIV-PAH. We observed that exposure of HIV-infected macrophages or HIV-Trans-Activator of Transcription (Tat)-treated pulmonary endothelial cells to cocaine enhanced the expression of platelet-derived growth factor (PDGF)-BB. Simultaneous treatment with Tat and cocaine, on the other hand, exacerbated both the disruption of tight junction proteins (TJPs), with enhanced permeability in pulmonary endothelial cells, and the proliferation of pulmonary smooth muscle cells (pSMCs) compared with either treatment alone. Histological examination of HIV plus IVDU human lung sections showed signs of early pulmonary arteriopathy, severe down-modulation of TJPs, and increased expression of PDGF-BB compared with the lung sections from individuals who are infected with HIV and without history of IVDU. Interestingly, blocking of PDGF receptor signaling with the receptor antagonist or small interfering RNA has been shown to inhibit the increase in proliferation of pSMCs on Tat and cocaine exposure. Our results, therefore, support an additive effect of cocaine to HIV infection in the development of pulmonary arteriopathy through enhancement of endothelial dysfunction and proliferation of pSMCs, while also suggesting PDGF-PDGF receptor axis as a potential target for use in clinical intervention.
Dhillon
Navneet K
NK
Department of Molecular and Integrative Physiology, 3008 Hixon, University of Kansas Medical Center, 3901 Rainbow Boulevard, Kansas City, KS 66160, USA. ndhillon@kumc.edu
Li
Fang
F
Xue
Bing
B
Tawfik
Ossama
O
Morgello
Susan
S
Buch
Shilpa
S
Ladner
Amy O'Brien
AO
D000779:Anesthetics, Local / Q000009:adverse effects* / Q000494:pharmacology; D000077214:Becaplermin; D002478:Cells, Cultured; D003042:Cocaine / Q000009:adverse effects* / Q000494:pharmacology; D005786:Gene Expression Regulation / Q000187:drug effects / Q000276:immunology; D015658:HIV Infections / Q000276:immunology* / Q000378:metabolism / Q000473:pathology; D015497:HIV-1 / Q000276:immunology*; D006801:Humans; D006976:Hypertension, Pulmonary / Q000209:etiology / Q000276:immunology / Q000378:metabolism / Q000473:pathology; D008168:Lung / Q000276:immunology* / Q000378:metabolism / Q000473:pathology; D008264:Macrophages / Q000276:immunology / Q000378:metabolism / Q000473:pathology; D009130:Muscle, Smooth / Q000276:immunology* / Q000378:metabolism / Q000473:pathology; D010982:Platelet-Derived Growth Factor / Q000096:biosynthesis / Q000276:immunology; D020574:Proto-Oncogene Proteins c-sis; D020545:Respiratory Mucosa / Q000276:immunology* / Q000378:metabolism / Q000473:pathology
D000779:Anesthetics, Local; D010982:Platelet-Derived Growth Factor; D020574:Proto-Oncogene Proteins c-sis; D000077214:Becaplermin; D003042:Cocaine
Circulation. 1999 Jul 20;100(3):292-8
10411855
Blood. 1999 Jul 1;94(1):275-82
10381523
Am J Physiol Cell Physiol. 2003 Feb;284(2):C316-30
12529250
Am Heart J. 1995 Aug;130(2):398-9
7631626
AIDS. 2008 Sep;22 Suppl 3:S49-53
18845922
Biochem Biophys Res Commun. 2005 Aug 12;333(4):1107-15
15979050
Expert Rev Cardiovasc Ther. 2009 Oct;7(10):1263-71
19814669
J Virol. 1993 Jan;67(1):277-87
8416373
J Virol. 2004 Jan;78(2):779-89
14694110
Respir Med. 1996 Mar;90(3):171-4
8736210
Am J Respir Crit Care Med. 2003 May 15;167(10):1433-9
12615632
Life Sci. 2000 May 5;66(24):2357-69
10864098
Am J Physiol Lung Cell Mol Physiol. 2003 May;284(5):L826-33
12533438
Clin Microbiol Rev. 2002 Apr;15(2):310-26
11932235
Ann Intern Med. 2006 Jul 18;145(2):152-3
16847299
J Med Primatol. 2003 Aug;32(4-5):229-39
14498983
Acta Cardiol. 2004 Jun;59(3):323-30
15255466
Exp Lung Res. 2007 Sep;33(7):357-73
17849262
Am J Physiol. 1988 Dec;255(6 Pt 2):H1484-91
3144186
Chest. 1991 Nov;100(5):1268-71
1935280
Am Rev Respir Dis. 1992 May;145(5):1196-200
1586065
Stroke. 2007 Jul;38(7):2136-41
17525390
Clin Immunol. 1999 Apr;91(1):68-76
10219256
J Virol. 1991 Aug;65(8):4547-9
2072464
J Neuropathol Exp Neurol. 2005 Jun;64(6):498-505
15977641
Biochem Biophys Res Commun. 2003 Oct 10;310(1):135-42
14511660
J Am Coll Cardiol. 2004 Jun 16;43(12 Suppl S):13S-24S
15194174
AIDS. 2008 Sep;22 Suppl 3:S41-7
18845921
J Neurosci. 2008 Jul 30;28(31):7788-96
18667611
Vascul Pharmacol. 2008 Oct-Dec;49(4-6):113-8
18606248
J Biochem Mol Biol. 2005 Nov 30;38(6):725-38
16336789
J Immunol. 2001 Sep 1;167(5):2766-71
11509621
Chest. 1993 Aug;104(2):614-6
8101799
J Neuroimmune Pharmacol. 2008 Mar;3(1):52-6
18046654
Eur Respir J. 1995 Dec;8(12):2129-38
8666110
Cancer Res. 1993 Nov 15;53(22):5569-75
8221699
N Engl J Med. 2005 Sep 29;353(13):1412-3
16192491
AIDS. 2008 Sep;22 Suppl 3:S35-40
18845920
J Clin Invest. 2008 May;118(5):1846-57
18382765
Blood. 2006 Jun 15;107(12):4770-80
16478881
J Neurosci Res. 2003 Oct 15;74(2):255-65
14515355
AIDS. 2008 Apr 23;22(7):825-33
18427200
Lab Invest. 1986 Dec;55(6):632-53
3784535
J Immunol. 1993 May 15;150(10):4601-9
8482849
Am J Respir Crit Care Med. 2006 Aug 15;174(4):437-45
16728715
Chest. 2000 Oct;118(4):1133-41
11035689
Am J Respir Crit Care Med. 1995 May;151(5):1628-31
7735624
Eur Respir J. 1998 Mar;11(3):554-9
9596101
AIDS. 2010 Jan 2;24(1):67-75
19770696
Oncogene. 1992 Aug;7(8):1525-9
1630815
AIDS Res Hum Retroviruses. 2001 Jan 1;17(1):45-53
11177382
J Virol. 1992 Jul;66(7):4228-32
1602543
AIDS. 2007 Jan 30;21(3):307-16
17255737
Thorax. 2006 Aug;61(8):736
16877696
Am J Respir Crit Care Med. 2008 Jul 1;178(1):81-8
18420966
J Neurovirol. 2007 Dec;13(6):483-95
18097880
Biochem Biophys Res Commun. 2006 Aug 18;347(1):31-5
16806061
HIV Med. 2008 Aug;9(7):550-6
18557952
Chest. 2006 Dec;130(6):1657-63
17166979
J Immunol. 2007 Sep 1;179(5):2722-30
17709485
AIDS. 1996 Jun;10(7):701-10
8805860
J R Soc Med. 2001 Aug;94(8):384-90
11461981
Adv Cardiol. 2003;40:71-82
14533547
Am J Pathol. 2004 Sep;165(3):815-24
15331406
Mol Biol Cell. 2001 Oct;12(10):2934-46
11598182
J Cell Biol. 1994 Feb;124(3):365-71
8294518
Ann N Y Acad Sci. 2001 Nov;946:57-81
11762996
Am J Respir Crit Care Med. 2008 Jan 1;177(1):108-13
17932378
Am J Hypertens. 1997 Oct;10(10 Pt 1):1117-24
9370382
Eur J Immunol. 2001 Feb;31(2):376-83
11180101
Adv Exp Med Biol. 1998;437:199-205
9666272